Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO – Get Free Report) shares fell 5.7% on Thursday . The stock traded as low as $1.00 and last traded at $1.00. 1,620,059 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 4,001,855 shares. The stock had previously closed at $1.06.
Cardio Diagnostics Price Performance
The company’s 50-day simple moving average is $0.46 and its two-hundred day simple moving average is $0.95.
Institutional Trading of Cardio Diagnostics
Several institutional investors and hedge funds have recently modified their holdings of CDIO. Bank of America Corp DE bought a new stake in Cardio Diagnostics in the 1st quarter valued at $59,000. Prelude Capital Management LLC bought a new stake in Cardio Diagnostics in the 2nd quarter valued at $131,000. State Street Corp bought a new stake in Cardio Diagnostics in the 1st quarter valued at $163,000. Finally, Geode Capital Management LLC bought a new stake in Cardio Diagnostics in the 1st quarter valued at $290,000. 3.46% of the stock is currently owned by institutional investors.
Cardio Diagnostics Company Profile
Cardio Diagnostics Holdings, Inc, an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
- Five stocks we like better than Cardio Diagnostics
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Amazon, Target, Walmart in a race for fastest delivery
- How to Invest in Hotel Stocks
- Palo Alto Networks: the one security stock to rule them all
- How to Invest and Trade Chinese Stocks
- Is it time to buy the dip in Walmart shares?
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.